Headline News about Sarepta Therapeutics, Inc. - Common Stock![]() ![]() ![]() ![]() ![]()
Assessing Sarepta Therapeutics: Insights From 12 Financial Analysts
January 30, 2024
Via Benzinga
![]()
A Closer Look at 14 Analyst Recommendations For Sarepta Therapeutics
January 10, 2024
Via Benzinga
![]()
The Latest Analyst Ratings for Sarepta Therapeutics
December 12, 2023
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]()
Stocks Flip To Losses, Nvidia Defies Gravity, Bitcoin Pauses For A Breather: What's Driving Markets Tuesday?
January 09, 2024
Via Benzinga
Topics
Economy
Exposures
Interest Rates
![]() ![]() ![]() ![]() ![]() ![]() ![]()
Analyst Ratings for Sarepta Therapeutics
November 21, 2023
Via Benzinga
![]() ![]() ![]() ![]() ![]()
10 Health Care Stocks Whale Activity In Today's Session
December 27, 2023
Via Benzinga
![]() ![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|